Feedback / Questions
V66-Exatecan - Gennao Bio
https://www.businesswire.com/news/home/20240409718786/en/Gennao-Bio-Debuts-Preclinical-Data-for-First-in-Class-Antibody-Drug-Conjugate-from-Gene-Monoclonal-Antibody-Platform-GMAB-ADC
Apr 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious